Skip links

NUCLIDIUM wins EIC Accelerator grant

NUCLIDIUM wins EIC Accelerator grant to further advance its CuTrace platform for personalised cancer diagnostics


The European Innovation Council (EIC) has awarded Nuclidium with its Accelerator grant of €2,5 million to develop novel, broadly available Copper-based PET tracers for the diagnosis of a broad range of cancer indications. The EIC Accelerator program focuses on high impact innovations and on creating new markets. The innovations considered for funding should be cutting-edge, and particularly focused on scientific and/or technological discoveries.